Numerous anatomical and functional changes occurring in the aging kidney lead to reduced glomerular filtration rate, lower renal blood flow and impaired renal autoregulation. The elderly are especially vulnerable to the development of renal dysfunction and in this population acute renal failure (ARF) is a common problem. ARF is often iatrogenic and multifactorial; common iatrogenic combinations include pre-existing renal dysfunction and exposure to nephrotoxins such as radiocontrast agents or aminoglycosides, use of NSAIDs in patients with congestive cardiac failure and use of ACE inhibitors and diuretics in patients with underlying atherosclerotic renal artery stenosis. The aetiology of ARF is classically grouped into three categories: prerenal, intrinsic and postrenal. Prerenal ARF is the second most common cause of ARF in the elderly, accounting for nearly one-third of all hospitalized cases. Common causes can be grouped into true volume depletion (e.g. decreased fluid intake), decreased effective blood volume (e.g. systemic vasodilation) and haemodynamic (e.g. renal artery stenosis, NSAID use). Acute tubular necrosis (ATN) is the most common cause of intrinsic ARF and is responsible for over 50% of ARF in hospitalized patients, and up to 76% of cases in patients in intensive care units. ATN usually occurs after an acute ischaemic or toxic event. The pathogenesis of ATN involves an interplay of processes that include endothelial injury, microvascular flow disruption, tubular hypoxia, dysfunction and apoptosis, tubular obstruction and trans-tubular back-leak. Vasculitis causing ARF should not be missed as this condition is potentially life threatening. The likelihood of a postrenal cause for ARF increases with age. Benign prostatic hypertrophy, prostatic carcinoma and pelvic malignancies are all important causes. Early identification of ARF secondary to obstruction with renal imaging is essential, and complete or partial renal recovery usually ensues following relief of the obstruction.A comprehensive medical and drug history and physical examination are all invaluable. Particular attention should be paid to the fluid status of the patient (skin turgor, jugular venous pressure, lying and standing blood pressure, urine output). Urinalysis should be performed to detect evidence of proteinuria and haematuria, which will aid diagnosis. Fractional excretion of sodium and urine osmolality may be measured but the widespread use of diuretics in the elderly gives rise to unreliable results. Renal imaging, usually ultrasound scanning, is routinely performed for assessment of renal size and to exclude urinary obstruction. In some cases, renal biopsy is necessary to provide specific diagnostic information. The general principles of managing ARF include treatment of life-threatening features such as shock, respiratory failure, hyperkalaemia, pulmonary oedema, metabolic acidosis and sepsis; stopping and avoiding administration of nephrotoxins; optimization of haemodynamic and fluid status; adjustment of drug dosage appropria...
BackgroundReal time ultrasound guided percutaneous kidney biopsy has become the standard procedure to assess the pathology of native kidneys and renal transplants. No specific technique has shown to be totally free of post biopsy bleeding complications. Few Studies have looked at the rates of post biopsy bleeding complications comparing different needle size, post biopsy haematoma size, or clinical predictors of the complication rates. In this study we aim to assess safety and adequacy of the real time ultrasound guided biopsy using free hands (ultrasound-assisted) and ultrasound-guided technique.MethodThe results of 527 elective native and kidney transplant biopsy performed as a day case procedure at Lancashire Teaching Hospitals were retrospectively reviewed (499 native and 28 allograft biopsies). Biopsies were grouped into 4 groups according to the technique and the needle size; group 1 (n = 119; performed by free hands-ultrasound assisted- technique using 14G needle) Group 2 (n = 59; performed by free hands-ultrasound-assisted technique using 16G needle), group 3 (n = 195; performed by ultrasound-guided technique using 14G), and group 4 (n = 154; performed by ultrasound-guided technique using 16G). The 4 groups were matched in age, sex, weight, haemoglobin, serum creatinine, INR, PT, and PTT time.ResultsThe overall tissue specimen was adequate in 80.45 % of the cases, with no difference between group 1 and 3 (81.5 and 80.52 % respectively, p = 0.82) or between group 2 and 4 (86.44 and 77.3 % respectively, p = 0.13). The overall major complications rate was 2.84 %, with no difference between group 1 and 3 (2.5 and 1 % respectively, p = 0.30) or group 2 and 4 (5 and 4.5 % respectively, p = 0.86). The overall minor complications was 3.7 % with no difference between group 2 and 4 (3.3 and 5.84 % respectively, p = 0.46), however, minor complications were higher in group 1 compared to group 3 (5.8 and 1 % respectively, p = 0.01).There was no difference between using 14G and 16G needle size in terms of tissue adequacy(p = 0.7), major complications (p = 0.2 for drop in Hb >10 g/l, p = 0.08 for blood transfusion, p = 0.35 for embolization) or minor complication items(p = 0.4 for drop in Hb, 10 g/l,p = 0.1 for haematuria, p = 0.7 for hematoma).ConclusionWhen using a 14G needle, there is higher risk of minor complications in the free hands-(ultrasound-assisted) technique compared to the ultrasound-guided technique. There is no difference in the rates of major or minor complications between free hand and needle-guided technique using 16G needles. Both techniques showed adequate tissue sampling.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.